Evidence map›Paper›PMID 41892108›Full record

ReviewBiomimetics (Basel, Switzerland)2026

Advancements and Challenges in Tissue-Engineered Heart Valves: Integrating Biomechanics, Biomaterials, and Biomimetic Design for Functional Maturity.

Lorenzo Guidi, Elisabetta Rosellini, Gaia Riccio, Maria Grazia Cascone

Abstract readReview
In one paragraph

Review in Biomimetics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Advances in Biomimetics: Patents from Nature.Biomimetics (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lorenzo GuidiDepartment of Civil and Industrial Engineering, University of Pisa, 56126 Pisa, Italy.ORCID 0009-0003-5544-4557
Elisabetta RoselliniDepartment of Civil and Industrial Engineering, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0003-0248-2878
Gaia RiccioDepartment of Civil and Industrial Engineering, University of Pisa, 56126 Pisa, Italy.
Maria Grazia CasconeDepartment of Civil and Industrial Engineering, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-0037-7807

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Valvular heart disease remains a major global health burden, with currently available prosthetic heart valves failing to fully reproduce the adaptive, regenerative, and long-term functional properties of native valves. Tissue-engineered heart valves (TEHVs) have emerged as a promising alternative, aiming to develop living valve replacements capable of growth, remodeling, and physiological integration. However, despite substantial progress, the clinical translation of TEHVs remains limited, indicating the need for design strategies that go beyond material selection toward functionally mature constructs. This review presents recent advances in TEHV development from a biomimetic perspective, using native heart valves as a biological reference characterized by hierarchical structure, anisotropic mechanical behavior, mechanoresponsive cell populations, immune regulation, and temporally coordinated remodeling. We integrate current understanding of valve biology and mechanobiology with advances in scaffold materials and architecture, bioactive functionalization, biomechanical conditioning, and emerging fabrication and monitoring technologies. We discuss how biomimetic scaffold designs aim to replicate native extracellular matrix organization and nonlinear mechanics, how biological cues are used to regulate thrombosis, immune response, and cell recruitment, and how dynamic bioreactor systems support functional tissue maturation through controlled mechanical stimulation. Finally, key challenges for clinical translation are highlighted, and future directions are outlined, emphasizing integrated and biomimetically informed design approaches. Overall, this review aims to define guiding principles that may accelerate the development of durable, regenerative, and clinically translatable tissue-engineered heart valves. We argue that successful TEHV translation requires synchronized control of scaffold anisotropy, immune modulation, and mechanical conditioning rather than incremental material optimization.

Indexed as

biological cuesbiomimetic designbioreactorsfunctional maturationheart valve mechanobiologyscaffold architecturetissue-engineered heart valves

Identifiers

PMID41892108
PMCPMC13023917

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.